Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03408743 · ClinicalTrials.gov registry record · NA

Engineering an Online STI Prevention Program: CSE2

A NA study, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
2,946
Enrollment target

NCT03408743: Completed NA study, sponsored by Penn State University.

NCT03408743 is a NA study that has completed, run by Penn State University. The registered enrollment target is 2,946 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (110% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03408743, a NA study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
2,946 participants
Enrollment target

Study Summary

The overall objective of the proposed research is to reduce the incidence of sexually transmitted infections (STIs) among college students. The investigators propose to accomplish this by using the innovative, engineering-inspired multiphase optimization strategy (MOST) to develop a highly effective, appealing, economical, and readily scalable internet-delivered behavioral intervention targeting the intersection of alcohol use and sexual risk behavior. The rate of STIs on college campuses is alarming: one in four college students is diagnosed with an STI at least once during their college experience. Sexual activity when drinking alcohol is highly prevalent among college students. Alcohol use is known to contribute to the sexual risk behaviors that are most responsible for the transmission of STIs, namely unprotected sex, contact with numerous partners, and "hook-ups" (casual sexual encounters). Few interventions have been developed that explicitly target the intersection of alcohol use and sexual risk behaviors, and none have been optimized. In order to reduce the incidence of STI transmission among this and other high-risk groups, a new approach is needed. MOST is a comprehensive methodological framework that brings the power of engineering principles to bear on optimization of behavioral interventions. MOST enables researchers to experimentally test the individual components in an intervention to determine their effectiveness, indicating which components need to be revised and re-tested. Given the high rates of alcohol use and sex among college students, the college setting provides an ideal opportunity for intervening on alcohol use and sexual risk behaviors. The proposed study will include a diverse population of college students on 4 campuses which will increase the generalizability of the findings. The specific aims are to (1) develop and pilot test an initial set of online intervention components targeting the link between alcohol use and sexual risk behavio

Primary Outcome

This scale consists of 6 items and will be created as a weighted scale score. Analyses will report the mean and standard deviation and expected mean values from a regression analysis. The scale will reflect the average perceived prevalence of the alcohol and sex behaviors.

Interventions

  • BEHAVIORAL Self-efficacy alone
  • BEHAVIORAL Perceived benefits alone
  • BEHAVIORAL Knowledge Alone
  • BEHAVIORAL Benefits and self-efficacy
  • BEHAVIORAL Injunctive norms alone

Trial Details

FieldValue
Enrollment Target 2,946 participants
Start Date 2017-09-18
Est. Completion 2017-12-31
Phase NA
Penn State University

219 total trials

What the finished NCT03408743 record still lists

NCT03408743 is an interventional study that assigns participants to a tested intervention. Its 2,946 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (110% higher).

The record links to 0 conditions, and to 5 interventions - of which Self-efficacy alone is the first listed.

NCT03408743 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03408743 about?

NCT03408743 is a clinical study titled "Engineering an Online STI Prevention Program: CSE2". The overall objective of the proposed research is to reduce the incidence of sexually transmitted infections (STIs) among college students. The investigators propose to accomplish this by using the innovative, engineering-inspired multiphase optimization strategy (MOST) to develop a highly effective...

What is the current status of trial NCT03408743?

This trial is currently completed. It is a NA study. The enrollment target is 2,946 participants. The study started on 2017-09-18. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT03408743?

The interventions under investigation include: Self-efficacy alone (BEHAVIORAL), Perceived benefits alone (BEHAVIORAL), Knowledge Alone (BEHAVIORAL), Benefits and self-efficacy (BEHAVIORAL), Injunctive norms alone (BEHAVIORAL).

Who is sponsoring clinical trial NCT03408743?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03408743's enrollment target sits among peer trials

2,946 43rd of 2000 higher than 1,958 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05849961 · 2,946 participants

    Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

  • NCT03331380 · 2,950 participants · NA

    Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

  • NCT05564377 · 2,900 participants · Phase 2

    Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • NCT07222995 · 2,900 participants · NA

    Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03408743, the US trial registry maintained by the National Library of Medicine. NCT03408743 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.